Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001144204-10-008405)

Filing Details

Accession Number:: 0001144204-10-008405
Form Type:: 5
Zero Holdings:: No
Publication Time:: 2010-02-16 12:00:00
Reporting Period:: 2009-12-31

Filing Date:: 2010-02-16
Accepted Time:: 2010-02-16 17:29:33
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1137883	Brainstorm Cell Therapeutics Inc	BCLI	Biological Products, (No Disgnostic Substances) (2836)	912061050

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1303782	C Jonathan Javitt	C/O Brainstorm Cell Therapeutics Inc., 110 East 59Th Street New York, NY 10022		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2008-08-03	960,000	$275,000.00	960,000	No	4	P	Direct
Common Stock	Disposition	2009-09-29	213,988	$0.34	746,012	No	4	S	Direct
Common Stock	Disposition	2009-09-30	50,000	$0.32	696,012	No	4	S	Direct
Common Stock	Disposition	2009-10-01	2,800	$0.34	693,212	No	4	S	Direct
Common Stock	Disposition	2009-10-02	5,224	$0.34	687,988	No	4	S	Direct
Common Stock	Disposition	2009-10-05	87,509	$0.34	600,479	No	4	S	Direct
Common Stock	Disposition	2009-10-06	48,869	$0.34	551,610	No	4	S	Direct
Common Stock	Disposition	2009-10-14	60,000	$0.32	491,610	No	4	S	Direct
Common Stock	Disposition	2009-10-22	31,610	$0.32	460,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Mr. Javitt acquired these shares of common stock of Brainstorm Cell Therapeutics Inc. from ACCBT Corp. on August 3, 2008.